Diabetes Drugs Affect Pancreatic Cancer Risk

Metformin linked to lower risk in women; sulfonylureas, insulin associated with higher risk

TUESDAY, Jan. 31 (HealthDay News) -- Long-term use of the diabetes drug metformin is associated with a lower risk of pancreatic cancer only in women, while long-term use of sulfonylureas and insulin are associated with a significantly higher risk of pancreatic cancer, according to a study published online Jan. 31 in the American Journal of Gastroenterology.

Michael Bodmer, M.D., from the University of Basel in Switzerland, and colleagues investigated the correlation between use of diabetes drugs and pancreatic cancer from 2,763 patients diagnosed with pancreatic cancer and 16,578 matched controls (mean age, 69.5 years old; 46.2 percent male).

The researchers found that, although long-term use of metformin (≥30 prescriptions) did not affect the risk of pancreatic cancer overall (adjusted odds ratio [aOR], 0.87; 95 percent confidence interval [CI], 0.59 to 1.29), long-term use was associated with a lower risk in women (aOR, 0.43; 95 percent CI, 0.23 to 0.80). A significantly increased risk of pancreatic cancer was seen with long-term use of sulfonylureas (≥30 prescriptions: aOR, 1.90) and insulin (≥40 prescriptions: aOR, 2.29).

"Use of metformin was associated with a decreased risk of pancreatic cancer in women only, whereas use of sulfonylureas and of insulin was associated with an increased risk of pancreatic cancer," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

Dogs as Pets, Visitors, Therapists and Assistants
Home Healthcare Nurse, November/December 2014
Free access will expire on January 5, 2015.


Tracheostomy Care
Nursing2014 Critical Care, November 2014
Free access will expire on December 22, 2014.


Effective management of ARDS
The Nurse Practitioner, 13December 2014
Free access will expire on December 22, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events